Physician profile
David Kolomer
NPI 1871932038
$4,867.09
in general payments reported to CMS, 2019-2025
29 companies · $876 in 2025
The $876 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,515 · 2022: $267 · 2023: $903 · 2024: $1,305 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,448 · Education: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,447.59 |
| Education | $637.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,106.05 | 2021-2023 | Urolift |
| Astellas Pharma US INC | $1,029.15 | 2021-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $334.67 | 2021-2025 | |
| Urogen Pharma, INC. | $260.44 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $212.38 | 2023-2025 | Pylarify |
| Janssen Biotech, INC. | $199.01 | 2022-2025 | Erleada |
| Blue Earth Diagnostics | $194.28 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $172.32 | 2023-2025 | |
| Tolmar, INC. | $162.92 | 2023-2025 | Eligard |
| Sumitomo Pharma America, INC. | $161.11 | 2023-2025 | Orgovyx, Gemtesa |
| Palette Life Sciences, INC. | $136.07 | 2021 | |
| Endo USA, INC. | $131.02 | 2024-2025 | Xiaflex, Aveed, Edex |
| Hollister Incorporated | $98.60 | 2022-2023 | Infyna Chic, Vapro Pocket, Vapro |
| Novartis Pharmaceuticals Corporation | $90.52 | 2024-2025 | |
| Antares Pharma, INC. | $79.25 | 2021-2024 | Xyosted, Tlando, Nocdurna |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $74.62 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $69.91 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $56.61 | 2023-2024 | |
| Boston Scientific Corporation | $42.21 | 2023 | Ams 700 Cxr Rte Kit |
| Laborie Medical Technologies Corp. | $34.87 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Dentsply Ih Ab | $32.32 | 2025 | Lofric |
| Medtronic, INC. | $29.70 | 2025 | Interstim |
| Axonics, INC. | $29.23 | 2021 | |
| Merck Sharp & Dohme LLC | $24.96 | 2024 | Keytruda |
| Myriad Genetic Laboratories, INC. | $23.47 | 2022 | |
| Abbvie INC. | $21.39 | 2023 | |
| Integra Lifesciences Corporation | $20.85 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Profound Medical Corp. | $20.45 | 2025 | Tulsa-Pro |
| Urovant Sciences INC | $18.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kolomer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.